IBDEI0I4 ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;="E/F" MISC DIAGNOSIS^11^25
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;="H" MISC DIAGNOSIS^13^25
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;="I" MISC DIAGNOSIS^14^25
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;="J/K/L" MISC DIAGNOSIS^15^25
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;="M" MISC DIAGNOSIS^16^25
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;="N/O" MISC DISGNOSIS^17^25
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;="P" MISC DIAGNOSIS^18^25
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;="V/W/X/Y/Z" MISC DIAGNOSIS^28^25
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;="S" MISC DIAGNOSIS^22^25
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=CANCER (NOT MELANOMA)^6^25
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;="G" MISC DIAGNOSIS^12^25
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;="R" DIAGNOSES^21^25
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;="T/U" MISC DIAGNOSIS^27^25
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=  ADJUSTMENT REACTION^2^25
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=  ANXIETY DISORDER^3^25
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=  BIPOLAR DISORDERS^5^25
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=  DEMENTIA^9^25
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=  DEPRESSION^10^25
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=  PAIN^19^25
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=  PERSONALITY DISORDERS^20^25
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=  SCHIZOPHRENIC DISORDERS^23^25
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=  SUBSTANCE ABUSE^24^25
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=SCREENING^25^25
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=SYMPTOMS^26^25
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=OTHER DIAGNOSES^29^25
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=V-CODES^30^25
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=  TELEHEALTH-SECONDARY ONLY^31^25
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=FACE-TO-FACE^1^26
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=INTERVENTION^2^26
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=CCHT VIDEO^4^26
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=OTHER^3^27
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=TELEBUDDY EDUCATION^4^27
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=CCHT MONTHLY MONITOR^2^27
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=CCHT HOME VISIT^1^27
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=TELEPSYCH^5^27
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=PRIMARY DIAGNOSIS^1^28
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=ANEMIA^1^29
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=COAGULATION DISORDERS^2^29
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^4^29
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=LYMPHOID NEOPLASMS^5^29
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=GI CANCER^8^29
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^9^29
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=MISC. NEOPLASMS^10^29
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=METASTATIC SITES^11^29
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=COUNSELING & SCREENING^12^29
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=HEMOGLOBINOPATHIES^3^29
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=GENITOURINARY NEOPLASMS^7^29
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=BREAST & GYN NEOPLASMS^6^29
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=ARTIFICIAL OPENING STATUS^13^29
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=PERSONAL HX OF CANCER^14^29
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=SPECIAL SERVICES^6^30
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=CHEMO NURSE PROCEDURES^2^30
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=INFUSION DRUGS^4^30
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=BLOOD PRODUCTS^1^30
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=DIAGNOSTIC PROCEDURES^3^30
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=OTHER DRUGS^5^30
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=NEW PATIENT^2^31
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=ESTABLISHED PATIENT^1^31
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=CONSULTATIONS^3^31
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=NEW PATIENT^2^32
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=ESTABLISHED PATIENT^1^32
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=CONSULTATIONS^3^32
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=MISCELLANEOUS TREATMENT^3^33
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^1^33
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^2^33
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^1^34
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=SECONDARY V CODES AS APPROPRIATE^1^35
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=C&P EXAM^1^36
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=LENGTHY/COMPLEX C-FILE REVIEW^1^37
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=PRIMARY DIAGNOSIS^1^38
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=INPATIENT ADMISSION VISIT^2^39
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=INPATIENT CONSULTS^1^39
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=INPATIENT SUBSEQUENT VISIT^3^39
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=DISCHARGE VISIT^4^39
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=OBSERVATION ADMISSION^5^39
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=OBSERVATION DISCHARGE^6^39
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=INTENSIVE CARE^7^39
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=CARDIAC^2^40
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=ENDOCRINE/METABOLIC^5^40
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=PULMONARY^20^40
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=EENT^4^40
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=MUSCULOSKELETAL^13^40
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=NEUROLOGIC^14^40
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=MENTAL HEALTH^12^40
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=GASTROENTEROLOGY^6^40
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=GU / RENAL^7^40
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=CANCER^3^40
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=HEMATOLOGIC & LYMPHATIC^8^40
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=INFECTIOUS DISEASE^10^40
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=SKIN^24^40
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^22^40
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=INTERSTITIAL LUNG DISEASE^11^40
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=PAIN^18^40
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=OTHER^17^40
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=COMMON PULMONARY DIAGNOSES^1^40
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^40
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=OCCUPATIONAL^16^40
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=PLEURAL DISEASE^19^40
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=RADIATION^21^40
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=SKELETAL^23^40
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=HEPATIC & BILIARY^9^40
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=SUTURES/DRESSINGS^25^40
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=VASCULAR^26^40
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=BEDSIDE PROCEDURES^1^41
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=BLOODS,ARTERIAL & VENOUS^2^41
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=BRONCHOSCOPY^3^41
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=EXERCISE TESTING^4^41
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=OXIMETRY^5^41
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=PULMONARY FUCTION TESTING^6^41
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=RESPIRATORY THERAPY^7^41
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=THORACENTESIS^8^41
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=NEW PATIENT^2^42
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=ESTABLISHED PATIENT^1^42
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=CONSULTATIONS^3^42
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=BIOPSY/DEBRIDEMENT^1^43
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=I&D/ASPIRATION^10^43
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^3^43
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=PARING/CUTTING^16^43
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=EXCISE BENIGN-SCALP/NECK/HAND/GENITAL/FT^5^43
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=EXCISE BENIGN-FACE/EAR/NOSE/LIP/LID^4^43
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=EXCISION BENIGN-TRUNK/ARM/LEG^6^43
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=EXCISE MALIG-FACE/EAR/NOSE/LIP/LID^7^43
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=EXCISE MALIG-SCALP/NECK/HAND/GENITAL/FT^8^43
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=EXCISION MALIG-TRUNK/ARM/LEG^9^43
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=REPAIR,SIMPLE-SCALP/NECK/TRUNK/EXTREM^21^43
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=REPAIR,SIMPLE-FACE/EAR/NOSE/LID/LIP^20^43
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=REPAIR,INTERMED-SCALP/TRUNK/LEG/ARM^19^43
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=REPAIR,INTERMED-FACE/EAR/NOSE/LID/LIP^17^43
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=REPAIR,INTERMED-NECK/HAND/GENITAL/FT^18^43
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=REPAIR-SIMPLE WOUND DEHISCENCE^22^43
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=NURSING PROCEDURES^14^43
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=BLOOD^2^43
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=IV INFUSION^11^43
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=MEDICATION^12^43
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=MEDICATION ADMINISTATION^13^43
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=PARACENTESIS^15^43
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=OTHER^23^43
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=POST-OP COMPLICATIONS^16^44
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^44
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=GYN/BREAST^8^44
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=MALE BREAST^10^44
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=BENIGN LESIONS OF SKIN^3^44
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^44
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=MELANOMA^12^44
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=LACERATIONS^9^44
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=MERKEL CELL CANCER^13^44
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=AFTERCARE POST SURGERY^2^44
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=CARDIOVASCULAR^4^44
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=ENT^5^44
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=ABDOMINAL PAIN^1^44
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=GI^7^44
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=RESPIRATORY^17^44
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=ORTHOPEDIC^14^44
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=PLASTIC SURGERY^15^44
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=UROLOGY^18^44
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=NEW PATIENT^3^45
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=ESTABLISHED PATIENT^1^45
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=CONSULTATION^2^45
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=DEMENTIA^1^46
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=ALCOHOL INDUCED MENTAL DISORDERS^2^46
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=DRUG INDUCED MENTAL DISORDERS^3^46
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=OTHER MENTAL/NEURO DISORDERS^4^46
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=PERSISTENT MENTAL D/O-OTHER CONDITIONS^5^46
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=TRANSIENT MENTAL D/O-OTHER CONDITIONS^6^46
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=FUNCTIONAL BRAIN MAPPING^2^47
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=CNS ASSESSMENTS/TESTS^1^47
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=NEW PATIENT^2^48
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=ESTABLISHED PATIENT^1^48
